Celgene Corporation

Available to platforms

Celgene Corporation (Ticker: CELG) was a global biopharmaceutical company specializing in the development and commercialization of therapies for cancer and inflammatory diseases. Its flagship products included Revlimid, a treatment for multiple myeloma, and Otezla, a therapy for psoriasis and psoriatic arthritis. In 2019, Celgene was acquired by Bristol Myers Squibb in a landmark $74 billion deal, expanding Bristol Myers Squibb’s oncology and immunology portfolio.

Celgene Corporation - CELG stocks live chart

Analyze price movements of Celgene Corporation online with R StocksTrader’s advanced stock charts. There's no need to manually refresh the chart as quotes are updated automatically in real-time. View both the current and previous CELG quotes – including the latest bid at 108.43 USD and ask at 108.48 USD – and get all the necessary information for adding Celgene Corporation to your investment portfolio.

With R StocksTrader, you can invest in Celgene Corporation and explore real stocks and CFDs on other prominent American and European companies. Stocks, Indices, Metals – over 12,000 assets are available for trading on our web terminal. Explore the dynamic price movements of popular assets, like Celgene Corporation, and expand your trading opportunities by investing in new instruments in 2025.

Risk Warning: Past performance of CELG does not predict future returns.

FAQ

Open a trading account at RoboForex, decide on the number of assets to buy and then place an order for Celgene Corporation (CELG).

You can trade Celgene Corporation (CELG) on the R StocksTrader platform.

You can trade online Celgene Corporation (CELG) on Prime, ECN, Pro, or R StocksTrader accounts.

All financial charts